Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 November 2020 | Story Thabo Kessah | Photo Thabo Kessah
Prof Geofrey Mukwada says funding from the US Embassy and Consulates in South Africa will reinforce the ARU mandate.

The University of the Free State (UFS) will further strengthen its ties with the Appalachian State University in the next two academic years through a mountain-to-mountain research project funded by the US Embassy and Consulates in South Africa.

The R8 million project between the UFS and the US institution will cover the two master’s degree programmes in underdeveloped niche areas, meteorological weather stations, leadership capacity building for black women in academia, and doctoral research projects. Qwaqwa Campus departments that will be involved are Physics, Geography, Community Development, and the ARU.

Talking about this collaboration, the project leader, Prof Geofrey Mukwada, said it would bring together researchers from both the UFS and Appalachian State University and enable them to work together to develop what is currently an underdeveloped research niche, i.e. mountain studies. 

“This project will reinforce the mandate of the Afromontane Research Unit (ARU). It will provide the basis for a long-term development agenda through training and infrastructure development. For instance, the project will fund the implementation of two master’s degree programmes – the MSc in Mountain Environments and the MA in Community Development – which are long-term projects,” he said. 

“It will also support innovation in climate change research. Through this project, it will be possible to receive climate data from weather stations that are situated in distant, isolated, and generally inaccessible locations without travelling to those locations. We will be able to understand how the climate of the region is changing and assist in developing adaptation measures and decisions that are applicable to agriculture, water, tourism, environment, and other sectors. This will enhance the capacity of the ARU to contribute to the development of research in mountain environments,” he added. 

There will be a virtual launch of the project on Tuesday 10 November 2020 at 15:00 (CAT).

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept